Request a Quote

Cyprotex Highlights - March 2022

2022 Header

It’s a toxicology special for our newsletter this month as we wrap up our seminar and poster presentations at SOT in San Diego.

If you missed us in person, our posters are now available to download on our event page:

SOT event page

In addition, if you are interested in our seminar presented at SOT, “Multi-Organ and Species-Specific Safety Profiling using Transcriptomics”, you can request a copy of the slides here:

Request SOT Seminar Slides

Not sure which of our SOT posters to read first? Head over to our blog to read an introduction to each one.

Read the blog on cardiotoxicity

Read the blog on DILI

Read the blog on neurotoxicity

Read the blog on immunotoxicity

Together with our colleagues at Evotec, we recently sat down with Springer Nature to talk about the potential of transcriptomics to herald a new era of toxicology prediction.

Click on the link below to read the full interview with Paul Walker, Rüdiger Fritsch and Carla Tameling:

Read the article

Contact us to find out more about how transcriptomics can be of use in your toxicology projects:

Enquire about transcriptomics

Evotec has published their latest Drug Discovery Update (DDup). This edition focusses on new developments in 3D cellular models and provides an overview of Evotec’s comprehensive in vitro 3D platforms.

Click on the link below to access the free publication:

Read the DDup

Read the latest news from parent company, Evotec:

  • Evotec enters into a collaboration with the University of Bristol to expand molecular patient database in the field of kidney diseasess
  • Evotec is selected as a winner of a 2022 CMO Leadership Award in the categories of Expertise (Small Pharma) and Service (Overall, Small Pharma)
  • Evotec receives € 3 m milestone payment from Bayer AG for starting Phase II clinical development of small molecule for diabetic neuropathic pain
  • Evotec expands high-throughput screening facilities at Hamburg HQ

Read the press releases

Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:

Read the blog

Contact us


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file